Navigation Links
Osteotech's Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio
Date:11/7/2008

EATONTOWN, N.J., Nov. 7 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, announced today that its next generation grafting material will be marketed under the brand name, MagniFuse(TM) Bone Graft.

Robert M. Wynalek, Osteotech's President - Domestic, commented, "The MagniFuse(TM) line of next generation bone regeneration products was developed in response to surgeon interest in a high performing, cost effective bone graft material. We believe that the distinctive properties of MagniFuse(TM) will redefine the bone grafting market and allow Osteotech to go head-to-head with bone morphogenetic protein products within the marketplace. This market is primed for a product that provides powerful bone formation and fewer complications, all at a cost effective price. We expect MagniFuse(TM) to be available for customers in the middle of 2009."

MagniFuse(TM) is a unique combination of allograft bone within a polymer mesh that will provide targeted and contained delivery. The polymer mesh is made from a biodegradable suture material and is designed for effective cellular in-growth and complete resorption within three to six months, while not interfering with bone regeneration. The polymer mesh provides a controlled environment for proximate allograft interaction eliminating issues with graft site migration or irrigation that is often seen with currently available bone graft substitutes. As previously announced, Osteotech has received 510(k) clearance from the United States Food and Drug Administration for MagniFuse(TM) as a bone graft substitute, and as a bone void filler, for use in the spine, pelvis and extremities.

The MagniFuse(TM) line of
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Osteotech Receives FDA Clearance for its Next Generation Grafting Material
2. Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler
3. Spring Point Project Welcomes Second Generation Medical-Grade Piglets
4. CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C.
5. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
6. Targeting Metastatic Cancer From the Inside: Epeius Biotech Reveals a New Generation of Tools for Medical Gene Delivery
7. PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program
8. Oklahoma CyberKnife Center Cuts Treatment Time in Half With Next Generation CyberKnife Technology
9. Introducing the next generation of chemical reactors
10. First Coast Oncology to Offer Next Generation Proton Therapy
11. Isilon IQ Powers Data Storage for Next-Generation DNA Sequencing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... CHARLOTTESVILLE, Virginia , September 2, 2015 /PRNewswire/ ... Sponsoring der Gewinner des Wettbewerbs BeHEARD von 2015 ... einen internationalen vom Rare Genomics Institute. ... Wirksamkeit von Medikamenten für die Behandlung anderer Krankheiten ... wurde, Steven Laffoon und sein Team ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... to creating professional commercial video content, to analysis of athletic performance. Producing ... that go by too quickly to process with the naked eye. , ...
(Date:9/1/2015)... The American Brain Tumor Association (ABTA) is now accepting ... program. LOIs are due no later than Wednesday, October ... Discovery Grants are one-year, $50,000 grants that fund high risk/high ... or treatment paradigms for adults and children with brain ... earliest stages, in the hopes that it spurs additional ...
(Date:9/1/2015)... ... September 01, 2015 , ... In her thought provoking debut novel ‘ Ebola ... not-so-distant future faced with an Ebola pandemic that is on the cusp of wiping ... enter the world of counterterrorism, and who continues to appear in this series of ...
Breaking Biology Technology:Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3American Brain Tumor Association Seeks Innovative Concepts For Discovery Research Grants 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 3
... in Additional Financing, YONKERS, N.Y., Oct. 28 ... announced today that it has,commenced a Phase IIb ... The Phase IIb trial is being conducted at ... by Eckhart Kampgen, M.D.,Associate Professor for Strategies of ...
... Colo., Oct. 28 N30 Pharma (N30), a,biopharmaceutical ... drugs that regulate nitric oxide bioavailability,announced today that ... Board of,Directors., N30 will use proceeds from ... Fibrosis and expand its discovery and preclinical,research in ...
... to $25 Million to Advance P-552, DURHAM, N.C., ... today announced that they have entered into an agreement ... treatment of dry mouth associated with primary Sjogren,s syndrome., ... the clinical,development of P-552. Kainos will provide funding to ...
Cached Biology Technology:Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123 2Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123 3N30 Pharma Announces Financing, Expansion of Board 2Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment 2Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment 3
(Date:8/5/2015)... York , August 5, 2015 ... report titled "Facial Recognition Market - Global Industry Analysis, ... the global market for facial recognition is forecast to ... driven by increased demand for surveillance systems by civil ... rising number of crimes and terrorist activities across the ...
(Date:8/4/2015)... (NASDAQ: AMRI ) today reported financial and operating results for ... , Second quarter contract revenue of $ 85.2 ... Adjusted contract margins of 26 % , ... in EPS from royalties in the current quarter , ... are very pleased to present another strong financial quarter, with all ...
(Date:7/31/2015)... 2015 BGI llevará a cabo la 10ª Conferencia ... 25 de octubre de 2015, en Shenzhen, ... décimo aniversario este año. Desde su inauguración en 2006, ... anuales más influyentes del mundo en los campos de ... más dinámicas, entusiastas y amenas. ICG-10 se ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... researchers from Oklahoma State University, the Samuel Roberts ... advance understanding of how socio-ecological systems can adapt ... the state. Oklahoma was one of ... Science Foundation Experimental Program to Stimulate Competitive Research ...
... of work carried out by the Carbohydrate Metabolism Research ... owned by the NUP/UPNA-Public University of Navarre, the Spanish ... the discovery has been made of the way in ... composition regulator", scoR) acts in bacteria and how the ...
... Swedish and Australian researchers present the miraculously preserved musculature of ... from a locality in north-west Australia. The finds will help ... "abs" evolved. The word "fossil" naturally conjures up ... more easily than soft tissues and are usually the only ...
Cached Biology News:OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3Discovery of how a gene that regulates factors involved in bacteria pathogenicity acts 2Discovery of how a gene that regulates factors involved in bacteria pathogenicity acts 3